Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
20,801,980
-
Shares change
-
+5,090,212
-
Total reported value, excl. options
-
$818,555,896
-
Value change
-
+$205,044,169
-
Number of buys
-
65
-
Number of sells
-
-19
-
Price
-
$39.35
Significant Holders of DECIPHERA PHARMACEUTICALS IN - COM (DCPH) as of Q2 2018
96 filings reported holding DCPH - DECIPHERA PHARMACEUTICALS IN - COM as of Q2 2018.
DECIPHERA PHARMACEUTICALS IN - COM (DCPH) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,801,980 shares
.
Largest 10 shareholders include New Leaf Venture Partners, L.L.C. (4,104,140 shares), ORBIMED ADVISORS LLC (2,005,700 shares), SV Health Investors, LLC (1,716,303 shares), Redmile Group, LLC (1,477,080 shares), Viking Global Investors LP (1,398,791 shares), FMR LLC (1,182,091 shares), VANGUARD GROUP INC (661,436 shares), Polar Capital LLP (594,551 shares), EMERALD ADVISERS INC/PA (592,224 shares), and BlackRock Inc. (591,064 shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.